NASDAQ: KZIA
Kazia Therapeutics Ltd Stock Ownership - Who owns Kazia Therapeutics?

Insider buying vs selling

Have Kazia Therapeutics Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when KZIA insiders and whales buy or sell their stock.

KZIA Shareholders

What type of owners hold Kazia Therapeutics Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Josiah T. Austin2.75%22,247,131$222.47MInsider
Dauntless Investment Group LLC0.01%118,139$1.18MInstitution
Barclays PLC0.00%24,000$240.00kInstitution
Rockefeller Capital Management LP0.00%10,700$107.00kInstitution
Ubs Group Ag0.00%3,543$35.43kInstitution
Citigroup Inc0.00%639$6.39kInstitution
Rhumbline Advisers0.00%591$5.91kInstitution
Arax Advisory Partners0.00%200$2.00kInstitution
Morgan Stanley0.00%200$2.00kInstitution
Mai Capital Management0.00%52$520.00Institution

1 of 2

KZIA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KZIA0.02%2.75%
DOMH7.92%56.66%Net SellingNet Selling
IMUX35.49%13.20%Net Buying
ATYR63.19%15.70%Net BuyingNet Buying
PYXS43.09%37.50%

Kazia Therapeutics Stock Ownership FAQ

Who owns Kazia Therapeutics?

Kazia Therapeutics (NASDAQ: KZIA) is owned by 0.02% institutional shareholders, 2.75% Kazia Therapeutics insiders, and 97.23% retail investors. Josiah T. Austin is the largest individual Kazia Therapeutics shareholder, owning 22.25M shares representing 2.75% of the company. Josiah T. Austin's Kazia Therapeutics shares are currently valued at $190.88M.

If you're new to stock investing, here's how to buy Kazia Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.